Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0

After our successful first Special Issue about bladder cancer, we proceeded with the second issue. Again, many international scientists submitted their newest research results in that extremely interesting field and followed our call for submissions. It is not only the collection and combination of...

Full description

Saved in:
Bibliographic Details
HerausgeberIn:
Sonstige:
Year of Publication:2021
Language:English
Physical Description:1 electronic resource (240 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 04486nam-a2201165z--4500
001 993545142804498
005 20231214133100.0
006 m o d
007 cr|mn|---annan
008 202105s2021 xx |||||o ||| 0|eng d
035 |a (CKB)5400000000040638 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/68385 
035 |a (EXLCZ)995400000000040638 
041 0 |a eng 
100 1 |a Ecke, Thorsten  |4 edt 
245 1 0 |a Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0 
260 |a Basel, Switzerland  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2021 
300 |a 1 electronic resource (240 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a After our successful first Special Issue about bladder cancer, we proceeded with the second issue. Again, many international scientists submitted their newest research results in that extremely interesting field and followed our call for submissions. It is not only the collection and combination of old and new markers that could develop new possibilities, but also the focus on different classifications and sub-classifications that will unveil new ways in diagnostic and therapeutic approaches. It seems that the two established diagnostic tools will still play an important role, but new markers and diagnostics tools will present more detailed and more differentiated possibilities in the treatment of urinary bladder cancer. This second Special Issue is full of scientific results that could provide new ways to help patients with instruments for early diagnostics and with predictive and prognostic markers on their way to finding new and personalized strategies for therapy. The editors thank all of the submitting authors for their efforts and time spent on each manuscript. We hope that this Special Issue will prove useful to research work in bladder cancer in the future. We hope that many talented researchers will use multiple forms of art to improve their professional successes and to ameliorate diagnostics and therapy in bladder cancer. 
546 |a English 
650 7 |a Medicine  |2 bicssc 
653 |a Metallothionein 
653 |a urothelium 
653 |a urothelial cancer 
653 |a cadmium exposure 
653 |a zinc transporter 
653 |a bladder 
653 |a TAGLN 
653 |a F-actin 
653 |a PTEN 
653 |a p53 
653 |a tumorigenesis 
653 |a proliferation 
653 |a invasion 
653 |a TERT promoter mutations 
653 |a FGFR3 
653 |a non muscle invasive bladder cancer 
653 |a BCG therapy 
653 |a bladder cancer 
653 |a JAK-STAT pathway 
653 |a combination therapy 
653 |a oncolytic adenovirus 
653 |a virotherapy 
653 |a STAT3/5 inhibitor 
653 |a JAK inhibitor 
653 |a XVir-N-31 
653 |a bladder cancer detection 
653 |a urinary biomarkers 
653 |a DNA methylation 
653 |a ECRG4 
653 |a ITIH5 
653 |a biomarker 
653 |a cancer 
653 |a grade 
653 |a metabolomics 
653 |a MS 
653 |a NMR 
653 |a biomarkers 
653 |a tumor markers 
653 |a prognosis 
653 |a heparanase 
653 |a syndecan-1 
653 |a heparan sulfate proteoglycans (HSPGs) 
653 |a urothelial carcinoma 
653 |a miRNA 
653 |a quantitative PCR 
653 |a tumor marker 
653 |a voided urine cytology 
653 |a KDM7A 
653 |a histone demethylase 
653 |a TC-E 5002 
653 |a androgen receptor 
653 |a drug resistance 
653 |a non-invasive detection 
653 |a telomerase 
653 |a somatic mutations 
653 |a TERT promoter region 
653 |a muscle-invasive bladder cancer 
653 |a chemotherapy 
653 |a immunotherapy 
653 |a personalized medicine 
653 |a predictive biomarker 
653 |a survivin 
653 |a BIRC5 
653 |a macrophage 
653 |a KRT20 
653 |a ERBB2 
653 |a MIBC 
653 |a prediction 
653 |a RT-qPCR 
653 |a adjuvant chemotherapy 
653 |a survival 
776 |z 3-03943-685-6 
776 |z 3-03943-686-4 
700 1 |a Otto, Thomas  |4 edt 
700 1 |a Ecke, Thorsten  |4 oth 
700 1 |a Otto, Thomas  |4 oth 
906 |a BOOK 
ADM |b 2023-12-15 05:42:22 Europe/Vienna  |f system  |c marc21  |a 2022-04-04 09:22:53 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337915360004498&Force_direct=true  |Z 5337915360004498  |b Available  |8 5337915360004498